The Usage Of Government Formulary For BPJS Inpatients With Ischemic Stroke In Indonesia
DOI:
https://doi.org/10.51601/ijhp.v4i3.347Abstract
Introduction: Ischemic stroke patients tend to use some medicine. In National Health Security (JKN), the government has created a government formulary as quality control and cost control. The study aims to determine the percentage of government formulary in Hospitals and the affected factors. Method: It was cross sectional quantitative research. It used retrospective data from medical record and prescription of ischemic stroke inpatients from January to June 2019. The data collected include hospital characteristics, patient characteristics, supporting characteristics and treatment costs. Result: The data cames from 17 hospitals. Based on the inclusion and exclusion criteria, 257 medical records were analyzed. The average percentage of drug use was 73.22%. Its was influenced by the hospital class, the number of supporting examinations, the number of drug items. Type B and C hospitals used non government formulary. There were citicolin, mecobalamin, piracetam, neurotropic multivitamin, flunarizine. Conclusion: The average percentage of drug use was still less than 100%. There were still non government formulary drugs used for the therapy of inpatient ischemic stroke. The use of non government formulary drugs was influenced by the hospital class, the number of supporting examinations, the number of drug items.
References
Sacco RL, Kasner SE, Broderick JP, Caplan LR, Connors JJ, et al. An Updated Definition of Stroke for the 21st Century, A Statement for Healthcare Professionals From the American Heart Association/American Stroke Associa-tion. Stroke. 2013 Jul ;44(7) :2064-2089.
Hsieh FI, and Chiou HY.Stroke :morbidity,risk factors,and care in Taiwan. Journal of Stroke 2014; 16(2):59-64.
Chung JW, Park SH, Kim N, et al. Trial of ORG 10172 in acute stroke treatment (TOAST) classification and vular territory of ischemic stroke lessions diagnosed by diffusion-weighted ima-ging. Journal of the American Heart Association 2014;10:1161.
Juwita DA, Almasdy D, Hardini T. Evaluation of Antihypertensive Drug Usage in Ischemic Stroke Patients at the National Stroke Hospital Bukittinggi. Journal of Clinical Pharmacy Indonesia 2018;7(2):99–107
Sepriani R, Wahyuni FS, Almahdy A, Armal K. Indication accuracy of alprazolam use in stroke patients of Neurology Ward of National Stroke Hospital Bukittinggi - Indonesia. J Sains Farm Klin. 2014;1(1); 95–100.
Sumawa PMR, Wullur AC, Yamlean PVY. Evaluation of rationality in the use of antihypertensive drugs in hospitalized hypertensive patients at Prof. DR. R.D. Kandou Manado Teaching Hospital for the period of January–June 2014. Pharmacon. 2015:4(3);126–3.
Wei JW, Heeley EL, Jan S, Huang Y, Huang Q, Wang JG, et al. Variations and Determinants of Hospital Costs for Acute Stroke in China. PLoS ONE. 2010; 5(9): e13041. doi:10.1371/journal.pone.001304
Leander RB, Siok ST, Paul JN, Peter JK, William KR, Hospital Costs of Ischemic Stroke in the Netherlands, Neurology. 2015;84:2208–2215.
Trung QV, USA C, Minh VH, Huong TN, Arthorn R. Hospital Cost Analysis in Developing Countries: A Methodological Com-parison in Vietnam. Asian Journal of Pharmaceutics. Jan-March 2018 (Special Issue) | S8.
Zulfa M, Nanang MY, Susi AK, Cost Analysis of Stroke Disease in National Health Insurance Patients at Blam-bangan Banyuwangi Regional General Hospital, JMPF, 2019; 9(2): 76-87.
Manna, Iwan D. Cost Analysis Of Jamkesmas And Askes Insurance For Patients With Non Hemorrhagic Stroke In Sleman Hospital. Journal of Healthcare Management. 2013; 16 (1): 30 -6.
Asil T, Celik Y, Sut N, Celik AD, Balci K, Yilmaz A, et al. Cost of Acute Ischemic and Hemorr- hagic Stroke in Turkey. Clinical Neurology and Neurosurgery [Internet]. Elsevier BV; 2011; 113(2) Feb: 111–4 [cited 2012 Apr 18]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/ 21036465
Ikhsanudin WB, Evaluation of Inpatient Prescription Compliance with the Formulary at Karanganyar District Hospital in 2016, Publication Manu-script, Muhammadiyah University of Surakarta, 2018
Winda RP, Angga PK, Dolih G, The Relationship between Prescription Compliance with the National Formu-lary and Service Quality for Patients with National Health Insurance at General Hospitals in Bandung, Pharm Sci Res, April 2017; 4(1): 48 – 56.
Krisnadewi, Kusuma, A., Subagio, P.B., & Wiratmo. (2014). Evaluation of minimum service standards at the pharmacy installation of Waluyo Jati Kraksaan Regional General Hospital before and after the implementation of the Social Security Administering Body (BPJS) for Health. e-Journal Health Library, 2(2), 192-198.
Kushal A, Nirmal S, Hitav S. The Care And Cost of Acute Ischemic Stroke in a Stroke Unit of a Tertiary Care Hospital in Mumbai. JNeurosci Neurosurg. 2020 Nov;3(1);143-6. DOI : 10.31021/jnn.20203143.
Wang G, Zhang Z, Ayala C, Dunet DO, Fang J, et al. Costs of Hospitalization for Stroke Patients Aged 18-64 Years in the United States. J Stroke Cerebrovasc Dis. 2014 May-Jun;23(5):861-868.
Orathai K, Supasit P, Chairoj Z. Cost of Acute and Sub-Acute Care for Stroke Patients. J Med Assoc Thai 2012; 95 (10): 1266-77.
Huang YC, Hu CJ, Lee TH, Yang JT, Weng HH, Lin LC, et al. The impact factors on the cost and length of stay among acute ischemic stroke. J Stroke Cerebrovasc Dis 2013; 22: e152–e158.
Chen CM, Hsu HC, Chang CH, Lin CH, Chen KH, Hsieh WC, et al. Age-based prediction of incidence of complications during inpatient stroke rehabilitation: a retrospective longitudinal cohort study. BMC Geriatri. 2014; 14: 41.
Dahlan M., Setyopranoto I., Trisnantoro L. Evaluation of the Implementation of the National Health Insurance Program for Stroke Patients at Dr. Sardjito General Hospital. Indonesian Health Policy Journal. 2017;06(02):73-82.
Praja DS., Hasmono D., Syifa N. Study of Neuroprotective Drug Utilization in Ischemic Stroke Patients (Research at Dr. Saiful Anwar General Hospital Malang). Pharmacy Journal. 2013;10 (02):147-158.
Santi N., Ikawati Z., Satibi. Analysis of the Effectiveness of Piracetam in Stroke Patients in the Inpatient Ward of the Hospital 2013;3(4):263-268.
Wahyuddin M., Nurrochmad A., Harjaningsih W. Title: Comparison of the Effects of Piracetam and Citicoline Therapy on Improving Cognitive Function in Ischemic Stroke Patients. Journal of Pharmacy Service Manage-ment. 2013;3(4):255-262.
Goldstein LB., Bushnell CD., Adams RJ., et al., AHA / ASA Guideline Guidelines for the Primary Prevention of Stroke A Guideline for Healthcare Professionals From the American Heart Association / American Stroke Asso-ciation. American Heart Association, Journal. 2011;42(2):517-584.
Li L, Cai L (2008) [Analysis of medical charge and influencing factors of inpatients with stroke]. Chinese Journal of Health Economics 27.
Gao X-f, Zeng Q, Li Y-p, Zhang X-f (2005) Analysis of factors on expense in 1969 cases of stroke inpatients. Chinese Journal of Evidence-based Medicine 5: 110–116.
Tannerl, A., L. Rantil., W.A. & Lolol. (2015). Title: Evaluation of Generic Drug Prescription Service Implemen-tation for Outpatient BPJS Patients at Prof. Dr. R.D. Kandou Manado Teaching Hospital, January-June 2014 Period. Pharmacon, 4(4), 58-64.
Kwan J (2007) Care pathways for acute stroke care and stroke rehabilitation: from theory to evidence. J Clin Neurosci 14: 189–200.
Maryam A, Morteza A, Mahnaz S, Developing a national formulary based on a unified payment system in Iran, Electronic Physician, January 2017; 9 (1) : 3623 – 9.
Febriawati H. Yanuarti R. Puspasari R, Title: Analysis of Prescription Writing for Non-National Formulary Drugs in Non-PBI BPJS Participants at Bhayangkara Tk III Hospital Bengkulu in 2015. Proceedings of the National Seminar of IKAKESMADA "The Role of Healthcare Personnel in Achieving SDGs". January 26, 2017. 253-8.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Lukman Prayitno, Novita Novita, Sonya Esther, Erlina Puspitaloka Mahadewi
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
